[Liebert] Hematological Markers as Predictors of Treatment Outcomes with Lutetium 177 (<sup>177</sup>Lu)-DOTATATE in Patients with Advanced Neuroendocrine Tumors

samdp1925 Post time 2022-7-28 22:25:38 | Show all posts |Read mode
Reward10points

journal:Cancer Biotherapy and Radiopharmaceuticals

Authors:Swayamjeet Satapathy; Anish Bhattacharya; Ashwani Sood; Rakesh Kapoor; Rajesh Gupta; Apurva Sood; Prashant Sharma; Divya Khosla; Bhagwant Rai Mittal

Published date:2022-2-1

DOI:10.1089/cbr.2021.0053

Article link:http://dx.doi.org/10.1089/cbr.2021.0053

Article Source:Mary Ann Liebert Inc


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
dlbui Post time 2022-7-28 22:25:39 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    65

Latest Reply

Return to the list